Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers

123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid Cancer

(2020) Jolanta M. Durski et al.   CLINICAL NUCLEAR MEDICINE

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol

(2019) Amir Iravani et al.   THYROID

NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features

(2018) Catarina Tavares et al.   Endocrine Connections

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes

(2018) Ian Ganly et al.   CANCER CELL

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

(2018) Lara A Dunn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effectiveness of chemotherapy in advanced differentiated thyroid cancer: a systematic review

(2015) Ana Albero et al.   ENDOCRINE-RELATED CANCER

External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

(2015) Ana P. Kiess et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Update on External Beam Radiation Therapy in Thyroid Cancer

(2011) James D. Brierley   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

(2011) Debyani Chakravarty et al.   JOURNAL OF CLINICAL INVESTIGATION

Prognosis and Prognostic Factors for Distant Metastases and Tumor Mortality in Follicular Thyroid Carcinoma

(2011) Kiminori Sugino et al.   THYROID

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER